These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


428 related items for PubMed ID: 25408130

  • 1. The application of flow cytometry for evaluating biological aggressiveness of intracranial meningiomas.
    Lin YW, Tai SH, Huang YH, Chang CC, Juan WS, Chao LC, Wen MJ, Hung YC, Lee EJ.
    Cytometry B Clin Cytom; 2015; 88(5):312-9. PubMed ID: 25408130
    [Abstract] [Full Text] [Related]

  • 2. Application of flow cytometry for evaluating clinical prognosis and histopathological grade of human glioma.
    Lin YW, Tai SH, Chang CC, Chao LC, Wen MJ, Huang YH, Hung HY, Lee EJ.
    Neurol Res; 2016 Jul; 38(7):625-33. PubMed ID: 27264544
    [Abstract] [Full Text] [Related]

  • 3. DNA ploidy and cell-cycle analysis in intracranial meningiomas and hemangiopericytomas: a study with high-resolution DNA flow cytometry.
    Zellner A, Meixensberger J, Roggendorf W, Janka M, Hoehn H, Roosen K.
    Int J Cancer; 1998 Apr 17; 79(2):116-20. PubMed ID: 9583723
    [Abstract] [Full Text] [Related]

  • 4. Intracranial meningeal tumours in childhood: a clinicopathologic study including MIB-1 immunohistochemistry.
    Demirtaş E, Erşahin Y, Yilmaz F, Mutluer S, Veral A.
    Pathol Res Pract; 2000 Apr 17; 196(3):151-8. PubMed ID: 10729919
    [Abstract] [Full Text] [Related]

  • 5. The significance of immunohistochemical expression of Ki-67, p53, p21, and p16 in meningiomas tissue arrays.
    Terzi A, Saglam EA, Barak A, Soylemezoglu F.
    Pathol Res Pract; 2008 Apr 17; 204(5):305-14. PubMed ID: 18374497
    [Abstract] [Full Text] [Related]

  • 6. MIB-1 immunostaining and DNA flow cytometry in meningiomas.
    Yasue M, Akasaki Y, Numoto TR, Abe S, Abe T, Takeuchi Y, Tanaka J.
    Noshuyo Byori; 1996 Apr 17; 13(1):17-20. PubMed ID: 8916122
    [Abstract] [Full Text] [Related]

  • 7. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
    Boström J, Meyer-Puttlitz B, Wolter M, Blaschke B, Weber RG, Lichter P, Ichimura K, Collins VP, Reifenberger G.
    Am J Pathol; 2001 Aug 17; 159(2):661-9. PubMed ID: 11485924
    [Abstract] [Full Text] [Related]

  • 8. Correlation of histopathologic classification with proliferative activity and DNA ploidy in 120 intracranial meningiomas, with special reference to atypical meningioma.
    Myong NH, Chi JG.
    J Korean Med Sci; 1997 Jun 17; 12(3):221-7. PubMed ID: 9250918
    [Abstract] [Full Text] [Related]

  • 9. Comparative investigation of proliferation markers and their prognostic relevance in human meningiomas.
    Torp SH, Lindboe CF, Granli US, Moen TM, Nordtømme T.
    Clin Neuropathol; 2001 Jun 17; 20(5):190-5. PubMed ID: 11594503
    [Abstract] [Full Text] [Related]

  • 10. Recurrent and atypical meningiomas--a multiparametric study using Ki67 labelling index, AgNOR and DNA Feulgen staining.
    Ferraraccio F, Accardo M, Giangaspero F, Cuccurullo L.
    Clin Neuropathol; 2003 Jun 17; 22(4):187-92. PubMed ID: 12908755
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Correlation of apparent diffusion coefficient with Ki-67 proliferation index in grading meningioma.
    Tang Y, Dundamadappa SK, Thangasamy S, Flood T, Moser R, Smith T, Cauley K, Takhtani D.
    AJR Am J Roentgenol; 2014 Jun 17; 202(6):1303-8. PubMed ID: 24848829
    [Abstract] [Full Text] [Related]

  • 14. Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma.
    Bruna J, Brell M, Ferrer I, Gimenez-Bonafe P, Tortosa A.
    Neuropathology; 2007 Apr 17; 27(2):114-20. PubMed ID: 17494511
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ki-67 index as a predictive marker of meningioma recurrence following surgical resection.
    Mizrachi M, Hartley B, Saleem S, Hintz E, Ziemba Y, Li J, Goenka A, Schulder M.
    J Clin Neurosci; 2024 Jun 17; 124():15-19. PubMed ID: 38631196
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas.
    Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM.
    Cancer; 1998 Jun 01; 82(11):2262-9. PubMed ID: 9610708
    [Abstract] [Full Text] [Related]

  • 20. Clinicopathological variables, immunophenotype, chromosome 1p36 loss and tumour recurrence of 247 meningiomas grade I and II.
    Ruiz J, Martínez A, Hernández S, Zimman H, Ferrer M, Fernández C, Sáez M, López-Asenjo JA, Sanz-Ortega J.
    Histol Histopathol; 2010 Mar 01; 25(3):341-9. PubMed ID: 20054806
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.